Prosecution Insights
Prosecution Insights
8 pending office actions • 8 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (12%) |
| §103 only | 2 (25%) |
| Double-patenting only | 1 (12%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REILLY, SOPHIA JANE | 1 | 60.6% | +49.1% |
| FOWLER, ALAN JEROME | 1 | 100.0% | +0.0% |
| HAVLIN, ROBERT H | 1 | 51.6% | +27.9% |
| JAVANMARD, SAHAR | 1 | 65.3% | +34.8% |
| BAUER, BRIANNA LEE | 1 | — | — |
| KAPUSHOC, STEPHEN THOMAS | 1 | 46.7% | +53.2% |
| ISMAIL, REHANA | 1 | 77.3% | +32.8% |
| MATTISON, LORI K | 1 | 14.7% | +26.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18560316 | 6-HYDROXY-CANNABIDIOL-C4 | HAVLIN, ROBERT H | 8d overdue |
| 18546254 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | BAUER, BRIANNA LEE | 20d |
| 18560341 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | REILLY, SOPHIA JANE | 26d |
| 18258485 | IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY | KAPUSHOC, STEPHEN THOMAS | 34d |
| 18560337 | DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY | FOWLER, ALAN JEROME | — |
| 15640033 | CANNABINOID FORMULATIONS | MATTISON, LORI K | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18044941 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | ISMAIL, REHANA | 16d overdue |
| 18477467 | PHARMACEUTICAL COMPOSITION COMPRISING A CANNABINOID | JAVANMARD, SAHAR | 15d overdue |
| 18560316 | 6-HYDROXY-CANNABIDIOL-C4 | HAVLIN, ROBERT H | 8d overdue |
| 18560341 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | REILLY, SOPHIA JANE | 26d |
| 18258485 | IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY | KAPUSHOC, STEPHEN THOMAS | 34d |
| 15640033 | CANNABINOID FORMULATIONS | MATTISON, LORI K | — |
| Art Unit | Apps |
|---|---|
| 1627 | 1 |
| 1691 | 1 |
| 1626 | 1 |
| 1622 | 1 |
| 1623 | 1 |
| 1683 | 1 |
| 1625 | 1 |
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18560341 | RESCORCINOLS, METHODS FOR THEIR MANUFACTURE, AND USES THEREOF | REILLY, SOPHIA JANE | 1627 | §102§103§112Other | Non-Final OA | 26d | Pending | Nov 10, 2023 |
| 18560337 | DERIVATIVES OF CANNABIDIOL-C4 FOR THE TREATMENT OF EPILEPSY | FOWLER, ALAN JEROME | 1691 | §102§103 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18560316 | 6-HYDROXY-CANNABIDIOL-C4 | HAVLIN, ROBERT H | 1626 | §101§102§103§112Other | Non-Final OA | 8d overdue | Pending | Nov 10, 2023 |
| 18477467 | PHARMACEUTICAL COMPOSITION COMPRISING A CANNABINOID | JAVANMARD, SAHAR | 1622 | §103Other | Non-Final OA | 15d overdue | Pending | Sep 28, 2023 |
| 18546254 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH CANINE EPILEPSY | BAUER, BRIANNA LEE | 1623 | §102§103§112Other | Non-Final OA | 20d | Pending | Aug 11, 2023 |
| 18258485 | IDENTIFICATION AND TREATMENT OF PATIENTS WITH EPILEPSY | KAPUSHOC, STEPHEN THOMAS | 1683 | §102§112 | Non-Final OA | 34d | Pending | Jun 20, 2023 |
| 18044941 | USE OF CANNABIDIVARIN IN THE TREATMENT OF SEIZURES ASSOCIATED WITH RARE EPILEPSY SYNDROMES RELATED TO GENETIC ABNORMALITIES | ISMAIL, REHANA | 1625 | §103 | Non-Final OA | 16d overdue | Pending | Mar 10, 2023 |
| 15640033 | CANNABINOID FORMULATIONS | MATTISON, LORI K | 1619 | DP | Non-Final OA | — | Pending | Jun 30, 2017 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial